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Abstract
Background: Lymphatic filarial parasites survive within the lymphatic vessels for years despite the complex immune
environment surrounding them. Parasites possibly accomplish this by adopting various immunomodulatory strategies,
which include release of glutathione-S-transferases (GSTs) that counteract the oxidative free radicals produced by the host.
Since GSTs produced by parasites appear to be critical for the survival of parasites in the host, several studies evaluated the
potential of parasite GSTs as vaccine candidates especially against schistosomiasis, fascioliasis and Seteria cervi. However,
vaccine potential of GSTs of lymphatic filarial parasites has not been evaluated before.
Methods/Principal Findings: In the present study, the GST gene was cloned from the third stage larval (L3) cDNA libraries of
Wuchereria bancrofti, and recombinant GST (WbGST) was expressed and purified. Serum samples from individuals living in
an endemic area were analyzed for their reactivity with rWbGST. These findings showed that sera from endemic normal
individuals (EN) carry significant levels of anti-WbGST IgG antibodies compared to subjects who are microfilaraemic (Mf) or
show symptoms of clinical pathology (CP). Isotype analysis of the anti-WbGST IgG antibodies showed a predominance of
IgG1 and IgG3 antibodies in EN individuals. Subsequent functional analysis of the rWbGST showed that the rWbGST protein
retained the enzymatic activity of GST and the antibodies in EN sera could inhibit this enzymatic activity. Similar results were
obtained when anti-rWbGST antibodies raised in mice were used in the neutralization assay. Brugia malayi GST and WbGST
show significant sequence similarity. Therefore, to evaluate the vaccine potential of rWbGST, we used B. malayi L3 as
challenge parasites. Vaccine potential of rWbGST was initially evaluated by confirming the role of human and mice WbGST
antibodies in an antibody dependent cellular cytotoxicity (ADCC) assay. Subsequent vaccination studies in a jird model
showed that approximately 61% protection could be achieved against a B. malayi L3 challenge infection in jirds immunized
with rWbGST.
Conclusions: Results of this study show that rWbGST is a potential vaccine candidate against lymphatic filariasis. Nearly 61%
protection can be achieved against a B. malayi challenge infection in a jird model. The study also showed that the WbGST
protein retained the enzymatic activity of GST and this enzymatic activity appears to be critical for the survival of the
parasite in the host.
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Introduction
Lymphatic filariasis is a mosquito borne infection caused by
Wuchereria bancrofti, Brugia malayi or Brugia timori that affects 120
million people in 73 countries and another 1100 million people are
at risk [1,2]. Because of the gruesome pathology associated with
this infection, lymphatic filariasis is considered as a major obstacle
to economic development in endemic countries and identified as
the second leading cause of permanent and long-term disability.
Although excellent anti-filarial drugs are available, several rounds
of mass treatment are necessary to reduce the levels of infection
below those necessary to sustain transmission [3]. Therefore,
additional preventive measures such as vector control and vaccine
development are crucial to control the infection in endemic
regions. A certain population of individuals (called endemic
normal or EN) in the endemic area is refractory to the infection.
These individuals carry high levels of antibodies against the
parasite antigens which are believed to be protective [4].
Therefore, most of the vaccine studies were focused on identifying
the molecules recognized by these antibodies.
Especially, antigens of the infective third stage larvae of filarial
parasites are of special interest since they represent the first larval
stage that enters into the human host. Thus, anti-parasitic
mechanisms against these infective larvae can potentially prevent
the infection. Previous studies show that both antibodies and
effector cells are important in this anti-parasitic mechanism
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(ADCC) mechanism [5,6]. Studies have also demonstrated a role
for antibody and/or complement in the in vitro and in vivo cytotoxic
response to the larvae [7,8].
Lymphatic filarial parasites reside inside the lymphatic system
and bathe in lymph that carry immune cells and molecules, yet
they survive for years without any major harm and appear to be
not damaged by the oxidative free radicals released from the host
cells. This is largely possible because of the ability of the parasite to
produce and secrete molecules such as glutathione-S-transferases
(GSTs), SOD, catalase, glutathione peroxidase, peroxiredoxins [9]
that can neutralize cytotoxic products arising from reactive oxygen
species (ROS) that attack on cell membranes.
Neutralizing the effect of these molecules by immunization or
vaccination could affect the ability of the parasite to survive in the
host. A protective role for immunization with GSTs from several
helminth parasites including schistosomes, fasciola [10] and the
filarial parasite Seteria cervi have already been established [11–13].
The schistosome 28 GST has been successfully developed into a
vaccine against S. mansoni [14] and S. bovis [15,16]. The
mechanisms underlying the protection conferred following immu-
nization with S. mansoni 28 GST appears to be due to an
inactivation of the GST enzymatic activity [17]. Thus, neutralizing
the activity of GST may be a strategy to induce protection against
certain parasitic infections. Immunization of mice with Fasciola
gigantica GST26 could confer from 77–84% protection against
challenge infection in mice [18]. F. gigantica GST26 and S. mansoni
GST28 show significant sequence similarity such that immuniza-
tion of mice with recombinant F. gigantica GST26 could confer
cross protection against challenge infections with S. mansoni in
mice. Thus, GST appears to be a critical protein for the survival of
the parasite in the host. Based on homology sequences Nathan et al
[19] constructed the 3D structure of W. bancrofti GST (WbGST)
and predicted sites for docking of GST inhibitors as a new
approach to develop drugs against W, bancrofti. These studies
suggest that WbGST may be a promising target for vaccine
development. Therefore, in this study we have attempted to
evaluate the vaccine potential of filarial GST.
Methods
Brugia malayi parasites
B. malayi parasites (L3, mf, adult male and adult female) used in
this study were obtained from NIH/NIAID Filariasis reagent
repository center, College of Veterinary Medicine, University of
Georgia, Athens, GA.
Human sera samples
Blood samples were collected from the following clinical groups
after obtaining informed consent: 1) Endemic normal (EN)
subjects, who are asymptomatic, non-microfilaraemic and reside
in villages surrounding Sevagram, Wardha, India with no
symptoms of the disease; 2) Symptom-free microfilaraemic carriers
(MF) (identified positive by microscopic examination of night
blood smear); 3) chronic pathology (CP) patients who are visiting
the out-patient department of Kasturba Hospital and were
showing clinical symptoms of filariasis. Non-endemic normal
(NEN) blood samples were collected from undergraduate medical
students coming from non-endemic areas (such as Himachal
Pradesh and Jammu & Kashmir States of India) with no
circulating parasites and no evidence of filarial disease who were
registered at the time of their admission to Mahatma Gandhi
Institute of Medical Sciences, Sevagram. Use of human subjects in
this study was approved by the IRB committees at Department of
Biochemistry, Mahatma Gandhi Institute of Medical Sciences,
Sevagram, India and at the University of Illinois, Rockford, USA.
Sera separated from the blood samples were stored at 220uC
freezer until use.
Construction of pRSET A-W. bancrofti GST (WbGST)
expression plasmid
WbGST gene was amplified from WbL3 cDNA library using insert
specific primers (Forward: 59CGCGGATCCATGAGTTATAA-
ACTGAC39 and Reverse: 59CCGGAATTCTCACTGTTTTC-
CATTTCC39). PCR parameters were as follows: 94uCo fd e n a t u r -
ation for 30 s, 50uC of primer annealing for 30 s, 72uC of primer
extension for 30 s, and cycled for 30 cycles; a final extension of 5 min
was performed at 72uC. PCR products obtained were digested with
Bam HI and Eco RI enzymes and ligated to similarly digested T7
expression vector pRSET A (Invitrogen, Carlsbad, CA). Insert DNA
was sequenced on both strands to ensure authenticity of the cloned
nucleotide sequence. The pRSET A-WbGST construct was trans-
formed into E. coli BL21 pLysS to express the recombinant protein.
Expression and purification of rWbGST
The E. coli BL21 containing pRSET A-WbGST construct was
grown to A600 ,0.6 in LB medium containing ampicillin/
chloramphenicol at 37uC and the expression of rWbGST was
induced by the addition of isopropyl-b-D-thiogalactopyranoside
(IPTG) to a final concentration of 1 mM IPTG. The culture was
furtherincubatedfor another 3 h at 37uC. Bacteria were pelleted by
centrifugation and resuspended in phosphate-buffered saline (PBS;
150 mM NaCl, 50 mM Na2HPO4, 50 mM NaH2PO4 pH 8.0).
Finally, the cells were lysed by sonication and the debris was
precipitated by centrifugation at 12000 rpm at 4uC for 20 min.
Collected supernatant was passed through immobilized cobalt
metal affinity column chromatography (Clontech, Mountain
View, CA) to purify the His tagged rWbGST as per manufactur-
er’s instructions. The expression pattern and purity were analyzed
by 15% SDS PAGE. Presence of Histidine-tag in the purified
protein was detected using penta His-HRP monoclonal antibodies
(Qiagen, Valencia, CA). Concentration of protein was estimated
by micro BCA method (Thermo Fisher, Rockford, IL).
Author Summary
Lymphatic parasites survive for years in a complex immune
environment by adopting various strategies of immune
modulation, which includes counteracting the oxidative
free radical damage caused by the host. We now know that
the filarial parasites secrete antioxidant enzymes. Among
these,the glutathione-S-transferases (GSTs)havethe potent
ability to effectively neutralize cytotoxic products arising
from reactive oxygen species (ROS) that attack cell
membranes. Thus, GSTs have the potential to protect the
parasite against host oxidative stress. GSTs of several
helminthes, including schistosomes, fasciola and the filarial
parasite Seteria cervi, are also involved in inducing
protective immunity in the host. The schistosome 28 kDa
GST has been successfully developed into a vaccine and is
currently in Phase II clinical trials. Thus, GST appears to be a
potential target for vaccine development. Therefore, in the
present study, we cloned W. bancrofti GST, and expressed
and purified the recombinant protein. Immunization and
challenge experiments showed that 61% of protection
could be achieved against B. malayi infections in a jird
model. In vitro studies confirm that the anti-WbGST
antibodies participate in the killing of B. malayi L3 through
an ADCC mechanism and enzymatic activity of WbGST
appears to be critical for this larvicidal function.
WbGST Vaccination for Lymphatic Filariasis
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GST(s) enzyme activity was determined spectrophotometrically
at 340 nm by measuring enzymatic conjugation of glutathione
with 1-chloro-2, 4-dinitrobenzene (CDNB) [20]. Nonenzymatic
conjugation with addition of reaction mixtures without the enzyme
served as controls. Under standard assay conditions, the reaction
mixture contained 100 mM phosphate, pH 6.5, 1.0 mM CDNB
in ethanol, 1.0 mM GSH, and enzyme protein. A unit of enzyme
activity was expressed as the amount that catalyzes the formation
of 1 mmol S-2, 4-dinitrophenyl-GSH adduct per minute, using a
molar extinction coefficient of 9.6 mM
21 cm
21 for CDNB.
Screening human sera for WbGST antibodies
Sera from different groups of subjects from the endemic and
non-endemic regions were screened for the presence of antibodies
against recombinant WbGST using both Immunoblot analysis and
an indirect ELISA. For immunoblot analysis, rWbGST protein
was separated on 15% SDS-PAGE, transferred to nitrocellulose
membrane and blocked overnight with 5% skimmed milk. After
washing, the membrane strips were incubated individually with
diluted (1:50) pooled sera from MF, CP, EN or NEN individuals.
The bound antibodies were probed with HRP labeled mouse anti-
human IgG and color was developed with DAB/H2O2 chromo-
genic-substrate complex (Thermo fisher Scientific).
An indirect ELISA was performed to measure the level of IgG
antibodies in individual sera sample. A total of 176 sera samples
belonging to 45 microfilaraemics (Mf), 45 chronic pathology (CP),
43 endemic normal (EN) and 39 non endemic normal (NEN)
individuals were screened for anti WbGST IgG antibodies using
rWbGST as antigen in the indirect ELISA. Briefly, wells of an
ELISA plates were coated with 1 mg/ml of rWbGST. After
blocking the non-specific binding sites human sera samples were
added at 1:100 dilutions. After washing the plates, horse radish
peroxidase labeled anti human IgG (1:10000; Sigma, St. Louis,
Missouri) was added and color was developed using OPD substrate.
Isotype of anti-rWbGST IgG antibodies were also analyzed in
the sera of various study groups by indirect ELISA using
biotinylated mouse monoclonal antihuman IgG1, IgG2, IgG3
and IgG4 and probed with avidin-horse-radish-peroxidase (Sigma,
St. Louis, Missouri) as the secondary antibodies.
Immunization of mice and jirds with rWbGST
Use of animals in this study was approved by the IACAUC
committee at the UIC College of Medicine, Rockford and by the
Institutional Animal Ethics Committee (IAEC) under the guide-
lines of Committee for the purpose of control and supervision on
experiments on Animals (CPCSEA), Wardha, India. Five 2
months old male Balb/c mice were immunized intraperitoneally
for antibody generation and seven two-months-old jirds were
immunized intraperitoneally with 15 mg of rWbGST per animal in
100 ml of 0.5 M PBS along with equal volume of alum (Thermo
fisher Biotech) as adjuvant. Three doses of the antigen were given
at 15 days interval followed by one booster dose. Age matched
control mice and jirds (five animals per group) received alum
alone. One week after the final booster dose, sera were collected
and tested for anti-WbGST IgG antibody levels. These sera
samples were also used in downstream ADCC assays to determine
their ability to kill B. malayi L3s in vitro.
Analysis of antibody levels
Total anti WbGST IgG antibody levels in the sera samples of
mice and jirds were determined using an indirect ELISA as
described above. HRP-labeled goat anti-mouse IgG (ThermoFisher
Scientific) was used as the secondary antibody. In addition, we also
determined the isotype of anti-WbGST IgG antibodies (IgG1,
IgG2a, IgG2bandIgG3)inthe mice sera usinga kit purchasedfrom
ThermoFisher Scientific. Color was developed using ABTS (2,29-
azinobis,3-ethylbenzothiazoline-6-sulfonic acid) substrate and ab-
sorbance was measured at 405 nm in a microplate reader.
Expression of GST in different life cycle stages of W.
bancrofti
WbGST gene was PCR amplified from the cDNA libraries of
third stage infective larvae (L3), microfilariae (MF) and adult
female (AF) of W. bancrofti using gene specific forward and reverse
primers. PCR conditions used were an initial denaturation at 94uC
for 5 min, 30 cycles (30 s at 94uC, 30 s at 50uC and 30 s at 72uC)
of amplification, and a final extension at 72uC for 5 min. The
amplified products were analyzed on a 1% agarose gel.
Depletion of anti WbGST antibodies from sera
Anti-WbGST antibodies in the sera of immunized mice and in
the pooled sera of EN individuals were depleted by passing the
sera over rWbGST coupled to Cobalt IMAC resin (Clontech).
Briefly, 1 mg of his-tagged rWbGST was coupled to the resin,
washed and incubated overnight at 4uC with about 200 ml of neat
sera. Supernatant was collected by centrifuging the resin mixture
for 2 min at 750 rpm. Depletion of anti-WbGST antibodies were
confirmed using an ELISA as described above.
Inhibition of enzymatic activity
Evaluation of the inhibition of GST catalytic activity by anti-
WbGST antibodies was determined as described previously using
chloro-2, 4-dinitrobenzene as the substrate for GST activity [21].
For inhibition assay, 6.5 mg of rWbGST suspended in 25 ml was
incubated with 20 ml of sera samples for 1 h at 37uC followed by
four h incubation at 4uC. Sera samples used in this assay were (i)
pooled sera samples from EN individuals, (ii) sera from immunized
mice, (iii) WbGST antibody depleted sera from immunized mice
and (iv) WbGST antibody depleted pooled sera from EN
individuals. After incubation, the residual enzymatic activity was
determined as described above. Results were compared with
control samples (preimmune mice sera or NEN sera) that were
processed similarly.
Neutralization of GST activity with cDNB
For neutralization of GST activity in the parasite, we followed
the method described by [22]. Briefly, B. malayi L3s were
incubated with 14 mM of 1-chloro-2, 4-dinitrobenzene for 2 hrs
at 37uC. Following these the cDNB-treated L3s were used in
antibody dependent cell cytotoxicity.
In vitro antibody-dependent cellular cytotoxicity (ADCC)
assay
To determine the cytotoxic effects of anti rWbGST antibodies
against B. malayi L3s, we performed an in vitro ADCC assay as
described previously [23]. Sera samples used in this assay were
from (i) EN individuals, (ii) immunized mice, (iii) WbGST
antibody depleted sera from immunized mice and (iv) WbGST
antibody depleted sera from EN individuals. Pre-immune or NEN
sera samples served as negative controls. Briefly the ADCC assay
was performed by adding 8–13 L3 of B. malayi to a suspension of
2610
5 peritoneal exudates cells (PEC) collected from normal
Balb/c mice or PBMC’s collected from NEN (WbGST antibody
negative) individuals. Approximately, 50 ml of the sera samples
were diluted with 50 ml of RPMI 1640 media and added to the
WbGST Vaccination for Lymphatic Filariasis
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then added to wells of a 96 well culture plates (ThermoFisher) and
incubated for 48 h at 37uC and 5% CO2. Larval viability was
determined under a light microscope 48 h after incubation.
Parasites those were limpid and straight with no movements were
counted as non-viable and if they were still limpid and straight for
the next 8 hours at 37uC, they were counted as dead. The live
larvae were still active. We followed the method used by [24].
Results were expressed as the ratio of immobile or dead parasites
to the total number of parasites recovered within each experiment.
In some studies we also used cDNB-treated B. malayi L3s to
neutralize the GST activity in the parasite and measure ADCC.
Heterologous challenge experiments in jirds
rWbGST immunized and control groups of jirds were
challenged intraperitoneally with 100 B. malayi L3 per animal10
days after the last dose of immunization. We decided on the
heterologous challenge for three reasons (1) sequence similarity of
WbGST and BmGST (2) lack of an animal model for W. bancrofti
and (3) due to the fact that W. bancrofti infections are more
prevalent in endemic countries than B. malayi.. 120 days after
challenge infection, animals were euthanized by intraperitoneal
injection of sodium pentabarbitol. Thorax and abdomen were
opened to collect adult filarial worms from abdominal cavity,
testes, heart, lungs and other organs. Number of adults worms
recovered from each animal was recorded.
Statistical analysis
Statistical analysis was performed using XL STAT software
v.7.5.2 (Kovach Computing Services, Anglesey, UK). Statistical
significance between comparable groups was estimated using
appropriate non-parametric tests, with the level of significance set
at p,0.05.
Results
Expression and enzymatic activity of rWbGST
Multiple sequence alignments of the amino acid sequences of
GST family of proteins from W. bancrofti (WbGST; accession
no. AY195867) were compared with other filarial parasites such as
B. malayi (BmGST, accession no. Y12788), Onchocerca volvulus
(OvGST, accession no. L28771) and Dirofilaria immitis (DiGST,
accession no. P46426). These analyses showed significant se-
quence identity between the various GSTs (Figure 1). Amino acid
Figure 1. Multiple sequence alignment of WbGST. Multiple sequence alignments (CLUSTAL) of the amino acid sequences of GST family of
proteins from W. bancrofti (WbGST; accession no. AY195867), Brugia malayi (BmGST, accession no. Y12788), Onchocerca volvulus (OvGST, accession
no. L28771) and Dirofilaria immitis (DiGST, accession no. P46426). The amino acid positions are numbered above the amino acid sequences. Multiple
alignment results show that GSTs from filarial parasites are highly identical to each other. (*) red color denotes identical amino acids, (:) green color
denotes strongly similar amino acids and (.) blue color denotes weakly similar amino acids.
doi:10.1371/journal.pntd.0000457.g001
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B. malayi GST, 79% identity with O. volvulus GST and 75%
identity with D. immitis GST. The ORF of WbGST cloned in
pRSET A was expressed as histidine tagged fusion protein. The
recombinant fusion protein with the histidine tag had a molecular
mass of approximately 28 kDa. SDS-PAGE analysis showed that
expressed rWbGST consisted .20% of the total E. coli proteins.
Subsequently, the recombinant protein was purified using metal
affinity column chromatography to near homogeneity (Figure 2).
After preparing purified rWbGST, GST enzyme activity was
determined using CDNB and GSH substrates. Our results showed
that purified rWbGST had significant enzyme activity
(1.02060.059 mM min
21 mg
21 of purified rWbGST protein).
EST database search of W. bancrofti showed the presence of only
phi- class of GST and did not show the existence of any other
classes of GST. Therefore, based on the sequence data and
enzymatic activity we believe that the GST cloned in this study
belongs to Phi-class of GST.
Humoral immune responses to rWbGST in endemic
population and in immunized mice/jird sera
Humoral immune responses to rWbGST were determined by
western blot analysis and ELISA. Immunoblot analysis confirmed
the presence of high levels of anti-WbGST antibodies in pooled
EN sera. However, anti-WbGST antibodies were absent in pooled
MF and NEN sera (Figure 3A). Sero-reactivity of individual
samples was then evaluated by an ELISA. EN sera had significant
amounts of anti-WbGST antibodies (p,0.001) (Figure 3B).
Analysis of the isotype of IgG antibodies showed that the anti-
WbGST IgG antibodies in the sera of EN individuals were
predominantly of IgG1 and IgG3 isotype (Figure 3C), whereas, the
IgG response from Mf individuals were predominantly IgG2
isotype. Interestingly, both EN and CP individuals had signifi-
cantly elevated levels of anti-WbGST IgG4 antibodies in their
sera.
Levels of anti-WbGST antibodies were also determined in the
sera of mice and jirds by ELISA. Results showed that both mice
and jirds immunized with rWbGST developed high antibody titer
(1:10000), whereas, control mice or jirds had no detectable
WbGST specific antibodies in their sera. Isotype profile of anti-
WbGST IgG antibodies showed that higher levels of both IgG1
(Th2) and IgG2a (Th1) anti-WbGST antibodies are present in
immunized animals (Figure 4).
Stage-specific expression of GST
Stage-specific expression of GST gene was investigated by PCR
using gene-specific forward and reverse primers from the cDNA
libraries of the various life stages of the W. bancrofti. This analysis
showed that transcripts of the GST gene were present predom-
inantly in the L3 stage of the parasite (Figure 5).
Inhibition of GST enzymatic activity by anti WbGST
antibodies
EN individuals carry antibodies against WbGST. To determine
whether these antibodies are functional, we performed a
neutralization assay. Results from these studies showed that sera
from EN individuals and from mice immunized with rWbGST
significantly inhibited WbGST enzyme activity compared to that
by NEN individuals and sera from control mice (p,0.001). The
level of inhibition of the GST enzyme activity by EN sera or
immune mouse sera was only approximately 50% of NEN or pre-
immune sera respectively.
To determine whether the GST inhibitory activity in the sera of
EN individuals and immune sera was due to anti-WbGST
antibodies, we first depleted WbGST specific antibodies from
the sera of immunized mice and from pooled sera of EN
individuals using rWbGST protein coupled to IMAC column. An
ELISA analysis confirmed that all the anti-WbGST antibodies
were completely depleted from the sera samples (data not shown).
Figure 2. Expression and purification of rWbGST. Cultures of E. coli containing pRSETA and rWbGST expression construct were induced with
1 mM IPTG. Following induction, rWbGST was purified from the cultures using a cobalt metal affinity chromatography column. Approximately 1 mgo f
the purified protein was then separated in a 15% SDS-PAGE and stained with coomassie brilliant blue R250. Lane 1- pRSET-A uninduced, Lane 2-
pRSET-A induced, Lane 3- rWbGST uninduced, Lane 4- rWbGST induced, Lane 5- Purified rWbGST and Lane M is protein molecular weight marker.
doi:10.1371/journal.pntd.0000457.g002
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also confirmed by western blot analysis (data not shown). The
antibody depleted sera were then used in the GST enzymatic
assay. These studies showed that depletion of anti-WbGST
antibodies from EN sera and from sera of immunized mice
resulted in the removal of GST enzyme inhibitory activity from
these sera samples. The anti-WbGST antibody depleted sera
behaved just like the NEN or pre-immune sera suggesting that the
anti-WbGST antibodies were potentially responsible for the GST
enzyme neutralizing activity (Figure 6).
In vitro ADCC
Previous studies showed that protective antibodies can kill
filarial parasites by ADCC mediated mechanism [5,25]. Since
GST appears to be an important enzyme used by the parasite to
neutralize the toxic molecules produced by activated cells in the
host [26], we wanted to evaluate whether targeting the parasite
GST with anti-WbGST antibodies can be lethal for the parasite or
not. Thus in this study, we evaluated the heterologous cytotoxic
effects of anti-rWbGST antibodies on B. malayi L3 using an in vitro
ADCC assay. Results from these studies showed that sera from
mice immunized with rWbGST promoted adherence of PEC to
L3 larvae (Figure 7), and induced significant death of L3s (70.56%
cytotoxicity) compared to L3s incubated with control sera (12.9%),
(p,0.001). Depletion of anti-WbGST antibodies from the
immune sera significantly reduced the L3 killing effect (21.43%),
(Table 1). We also neutralized the activity of BmGST in the
parasite by incubating B. malayi L3s with cDNB, a glutathione
depleting agent and repeated the ADCC assay using immune mice
sera and peritoneal cells. Results from these studies showed that
neutralizing the effect of BmGST activity in the parasite with
cDNB had no significant inhibitory effect on the ADCC ability of
immune sera (Table 1). Similar results were observed when anti-
WbGST-antibody-depleted EN sera were used in the ADCC
assay. Pooled EN sera promoted adherence of PBMC’s to L3 and
induced 89.94% death of L3s. Depletion of anti-WbGST from the
EN sera resulted in reduced L3 larval death (27.12%), (Table 2). In
these studies also we found that neutralizing the activity of
BmGST in the parasite by incubating B. malayi L3s with cDNB,
had no significant inhibitory effect on the ADCC ability of EN sera
Figure 3. Human immune responses to WbGST. A. Immunoreactivity of rWbGST with sera from different clinical groups of bancroftian filariasis.
Approximately 1 mg of rWbGST was resolved on 15% SDS-PAGE, transferred to nitrocellulose membrane and blots were probed with pooled sera
from MF, CP, EN or NEN individuals. Results showed strong immunoreactivity with pooled EN sera followed by CP and MF but no reactivity was
detected with control NEN sera. Data is representative of one of three experiments using the same sera samples. B. Humoral immune response to
rWbGST in human subjects. Total IgG levels against rWbGST in various clinical groups were evaluated by ELISA. Each data point represents single
individual absorbance from the four different groups. Horizontal lines represent geometric mean value of EN (43), Mf (45), CP (45) and NEN (39)
samples respectively. C. WbGST-specific IgG subclasses in the sera from different clinical groups. Isotype of anti-WbGST IgG antibodies in the sera
from various groups of human subjects (EN, MF, CP, TPE and NEN) were evaluated using an isotype-specific ELISA. Data presented is mean6SD value
from EN (43), Mf (45), CP (45) and NEN (39). * Significant (p,0.005) compared to all the other three groups (CP, MF and NEN). The statistical
significance was calculated by Kruskal–Wallis test.
doi:10.1371/journal.pntd.0000457.g003
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WbGST antibodies to promote cell mediated cytotoxicity is critical
for the WbGST vaccine-induced protection against lymphatic
filariasis infections.
Adult worm recovery in immunized jirds
To evaluate the significance of the in vitro killing of L3s by anti-
WbGST sera, we performed a vaccination trial and challenge
experiment in jirds. Ten days after the last dose of immunization,
jirds immunized with rWbGST or alum control were challenged
with 100 L3 larvae. On day 120, infected animals were autopsied
to determine the worm recovery. Mean adult worm recovery in
rWbGST immunized jirds was only 6.1760.42 whereas, control
jirds had 16.0 6 1.24 worms established (Table 3). This difference
was statistically significant and accounted for about 61.44%
reduction in parasite establishment in jirds immunized with
rWbGST compared to those in control jirds (p,0.005).
Discussion
Glutathione-S-transferases are extensively investigated as vac-
cine candidates against several parasitic infections [10–13]. The
present study describes cloning of WbGST gene from the cDNA
library of W. bancrofti and evaluating its potential as a vaccine
Figure 4. Subclass specific anti-WbGST IgG antibodies in the sera of mice immunized with rWbGST protein. Subclass analysis was
performed using a mouse antibody isotyping ELISA kit. The bars represent the mean O.D.6SD at 405 nm of five mice per group.
doi:10.1371/journal.pntd.0000457.g004
Figure 5. Stage-specific expression of filarial GST. WbGST gene was PCR amplified form W.bancrofti stage-specific cDNA libraries using WbGST
gene specific forward and reverse primers. Results show that the WbGST gene is predominantly expressed in the L3 stage of the W.bancrofti and is
barely detectable in adult female and microfilarial stages. Lane 1: 100 bp ladder; 2: W. bancrofti L3; 3: Adult Female; and 4: Mf.
doi:10.1371/journal.pntd.0000457.g005
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using sera samples from putatively immune individuals. Results
from our studies show that immunization with rWbGST confers
significant protection against a challenge infection with B.malayi in
jird model. Similarly, we show that naturally occurring anti-
WbGST antibodies in EN individuals can kill L3s of B. malayi in
vitro through an ADCC mechanism.
B. malayi and W. bancrofti are closely related parasites and show
significant antigenic overlap. Results of a blast search analysis
showed that WbGST gene has 98% homology with BmGST.
Similarly, antibodies generated against W. bancrofti antigens in
infected and immune individuals show significant cross reactivity
with B. malayi antigens [25]. Furthermore, since W. bancrofti
infections are more prevalent than B. malayi infections in several
parts of the world, we decided to test the prophylactic potential of
rWbGST. It is practically impossible to maintain W. bancrofti life
cycle in the laboratory, therefore, in these studies we used B. malayi
for heterologous challenge infections.
PCR screening of the cDNA libraries of different life cycle stages
of W. bancrofti showed that WbGST gene is expressed only in the
infective L3 stages. Since targeting the infective stages can block
the infection, WbGST appeared to be an attractive candidate for
evaluating the vaccine potential. Before evaluating the vaccine
potential we first determined whether WbGST retained the GST
enzymatic activity. This is critical because parasite GSTs behave
like mammalian GSTs in neutralizing oxidative radicals. By
neutralizing these noxious substances, the parasites are believed to
counteract the host mediated oxidative stress. Our results show
that rWbGST has significant GST enzyme activity. These findings
are similar to those reported for the trematode GSTs of S. mansoni,
S. japonicum [27] and F. hepatica [28]. Interestingly, the specific GST
activity (1.02 mmoles/min/mg) appears to be about 5–20% less
than that reported for Schistosoma or Fasciola GSTs using the
same substrate. WbGST cloned in this study belongs to Phi class.
Phi-class of Sm28GST, Phi-class of Sj26GST and Phi-class of
Fasiola GST all have low substrate specificities and inhibitor low
Figure 6. Anti-WbGST antibodies can neutralize the enzymatic activity of rWbGST. rWbGST was added to various test sera (pooled EN
sera, sera from mouse immunized with rWbGST, EN and mouse sera depleted of anti WbGST antibodies) and incubated for 1 hr at 37uC followed by
another incubation at 4uC for 4 h. Following incubation, GST enzyme activity was determined spectrophotometrically at 340 nm by measuring
enzymatic conjugation of glutathione with 1-chloro-2, 4-dinitrobenzene (CDNB). Individual bar represents mean6SD of GST activity (mM/min/mg).
Samples were read in triplicate wells. Data is representative of one of three similar experiments. Pre-immune sera from mice and sera from NEN
individuals were used as control samples. * Significant (p,0.005) compared to pre-immune or NEN sera samples. ** significant (p,0.01) compared to
non-depleted immune sera or EN sera samples.
doi:10.1371/journal.pntd.0000457.g006
Figure 7. Photomicrograph of L3 recovered from cultures after ADCC assay. A. L3s incubated in NEN sera and PBMCs. There are no cells
adhered to the larva and the larva was active. B. L3s incubated in EN sera and PBMCs. Note the cluster of cells adhered throughout the surface of
larvae, but more specifically to the anterior and posterior end of the larva.
doi:10.1371/journal.pntd.0000457.g007
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of GSTs in general have a low specific GST activity. Previous
studies using all these trematode GSTs suggest that parasite GST
is a potential vaccine candidate. Results from our current studies
support these findings and show that GST from filarial parasites
also has similar vaccine potential.
Putatively immune individuals (EN) carry antibodies to WbGST
in their sera. Majority of the antibodies are either of IgG1 or IgG3
Table 1. Results of antibody-dependent cellular cytotoxicity (ADCC) assay against heterologous B. malayi L3.
Groups (Pooled sera from 5 animals) Live Dead Total % Cytotoxicity (Mean6SD)
cDNB treated L3+rWbGST immunized mice sera+P E C 381 1
358
571 2
64.5267.4*
L3+rWbGST immunized mice sera+P E C 268
371 0
369
70.5664.19*
L3+rWbGST depleted mice sera+P E C 628
617
931 2
21.4366.19**
L3+Alum Control sera+P E C 718
819
11 2 13
12.962.17
In these assays, L3s were incubated with pooled immune mouse sera and 1610
5 peritoneal cells. One group of L3s were treated with 14 mM of 1-chloro-2, 4-
dinitrobenzene for 2 hrs then used in the ADCC assay.
*Statistically significant (p,0.001) compared to alum controls.
**Statistically significant (p,0.001) compared to non-depleted sera.
doi:10.1371/journal.pntd.0000457.t001
Table 2. Results of antibody-dependent cellular cytotoxicity (ADCC) assay against heterologous B. malayi L3.
Groups (Pooled sera of 10 individuals) Live Dead Total % Cytotoxicity (Mean6SD)
cDNB treated L3+EN sera+cells 3 7 10
29 1 1
36 9
72.8267.96*
L3+EN sera+cells 1 9 10
11 21 3
17 8
89.9462.40*
L3+rWbGST depleted EN sera+cells 9 3 12
82 1 0
74 1 1
27.1268.39**
L3+NEN sera+cells 8 0 8
90 9
10 0 10
0
In these assays, L3s were incubated with pooled sera from EN individuals and 1610
5 PBMCs. One group of L3s were treated with 14 mM of 1-chloro-2, 4-dinitrobenzene
for 2 hrs then used in the ADCC assay.
*Statistically significant (p,0.001) compared to alum controls.
**Statistically significant (p,0.001) compared to non-depleted sera.
doi:10.1371/journal.pntd.0000457.t002
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predominant role in the protection against this infection in human.
These individuals also showed significant increases in anti-
WbGST IgG4 antibodies similar to CP individuals. In another
study also we observed a similar Th2 biased responses following
immunization of mice with OvGST-2 of O. volvulus [29] or
rBmALT of B. malayi. In these studies also EN individuals were the
only one showing predominantly IgG1 and IgG3 antibody
responses [30,31]. Another interesting observation in the present
study was that MF individuals carry IgG2 antibodies against
WbGST in their sera suggesting largely a Th1 type response in
these individuals compared to putatively resistant EN individuals
who show a Th2 biased antibody responses in their sera.
Our studies also show that anti-WbGST antibodies in the sera
of EN individuals and sera of immunized mice have the capability
to neutralize parasite GST function. However, we failed to observe
100% inhibition of GST enzyme activity either with the EN sera
or with the immune mice sera. This could be possibly because (1)
the antibody titer was not optimized for maximum neutralization
of GST activity or (2) possibly the anti-WbGST antibodies could
only neutralize approximately 50% of the rWbGST activity.
Nevertheless studies by Morrison et al [10] suggest that there is no
correlation between titer of GST neutralizing antibodies and
protection against F. gigantica infections in mice. Yet studies by
Rathaur et al [29] showed that S. cervi GST activity could be
inhibited by sera from jirds that are vaccinated with S. cervi GST.
Similarly, Bal and Das [32] have also demonstrated inhibition of
S.digitata GST activity when incubated with sera from individuals
infected with W. bancrofti. Anti-S. mansoni 28 GST IgA antibodies
can neutralize the parasite GST activity in human schistosomiasis
and can impair in vitro hatching of S. mansoni eggs [17]. Thus, there
appears to be some indication that neutralizing the GST activity
may have adverse effect on the parasite. To test if neutralizing
WbGST activity will interfere with protection, we performed an in
vitro ADCC assay. Although this is not a direct measure of
protection, it does provide some important information about the
potential capabilities of anti-WbGST antibodies. Our in vitro
results clearly show that human anti-WbGST antibodies can
participate in the killing of infective L3s of B. malayi. Major
confirmation of this finding comes from the fact that depletion of
anti-WbGST antibodies from the EN sera eliminated the L3
killing effect. Since eliminating L3s are important in preventing
the infection, this finding also suggests that anti-WbGST may have
a crucial role in protection against this infection in EN individuals.
In addition, we also neutralized the activity of BmGST in the
parasite by incubating B. malayi L3s with cDNB, a glutathione
depleting agent and repeated the ADCC assay using EN sera and
PBMCs. Results from these studies show that neutralizing the
effect of BmGST in the parasite with cDNB had no inhibitory
effect on the ADCC ability of EN sera. Although in this study we
did not test whether we neutralized all the parasite GST activity
with cDNB, it appears that neutralization of GST activity is not
critical for ADCC function. These findings were similar to that
reported earlier by Morrison et al [10]. Thus, binding of specific
anti-WbGST antibodies to the parasite that promote cell mediated
cytotoxicity are critical for the WbGST vaccine-induced protec-
tion against lymphatic filariasis infections.
We were able to replicate the ADCC finding using a mouse
model as well. The mouse anti-WbGST antibodies were also able
to participate in the killing of B. malayi L3s in vitro and depletion of
the anti-WbGST antibodies from the mouse sera removed the L3
killing effect from the immune sera. These findings further suggest
that GST may be a critical protein for the survival of the B. malayi
L3. In our studies we did not identify the effector cells. Given that
majority of the anti-WbGST antibodies are of IgG subclass,
further studies evaluating the Fcc bearing cells might help identify
the effector cells that participate in the ADCC mechanism.
Mouse is not a permissive host in that the worms do not mature
into adults. Therefore, we did not conduct any challenge
experiments in the mouse model. Instead, we used a jird model
where the parasite matures into adult male and female parasites
[33]. Vaccine studies in jirds showed that 61% protection could be
achieved following immunization with rWbGST. Similar results
have been reported following vaccination with candidate GST
vaccine against other parasites [12,16]. These findings thus suggest
that WbGST may be a potential vaccine candidate. Our results
support and are in agreement with previous vaccination trials
using fasciola GST [10], schistosome GST [21,27], and O. volvulus
GST [29] that parasite GSTs are potential vaccine candidates for
controlling certain helminth infections in animals and human.
In conclusion, results presented in this study show that
putatively immune individuals in an endemic area carry antibodies
against WbGST. These antibodies can neutralize the parasite
GST activity and kill infective larvae of B. malayi that express the
Table 3. Data shows the number of adult worms recovered from jirds immunized with rWbGST or from control group of jirds after
a heterologous challenge infection with B. malayi L3 larvae.
Jird groups Adult worms recovered Total Recovered Mean worm burden Percentage Reduction
Control Male Female
Jird 1 8 5 13 16.061.24
Jird 2 6 10 16
Jird 3 11 8 19
Vaccinated
Jird 1 3 6 9 6.1760.42 61.44*
Jird 2 2 5 7
Jird 3 1 3 4
Jird 4 2 4 6
Jird 5 2 5 7
Jird 6 1 3 4
*Significant difference (p,0.005, Mann–Whitney U-test).
doi:10.1371/journal.pntd.0000457.t003
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can confer protection against a challenge infection. These findings
thus suggest WbGST could be potentially developed as a vaccine
candidate against lymphatic filarial parasites. Since only L3 stages
appear to express the WbGST protein it is likely that this
vaccination will be more effective in non-infected individuals as a
preventive vaccine.
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